Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -2015/16 group results

May 16 (Reuters)-  
          Taisho Pharmaceutical Holdings Co Ltd  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to       NEXT    
                Mar 31, 2016    Mar 31, 2015   Mar 31, 2017     YEAR      
                   LATEST         YEAR-AGO        COMPANY      COMPANY    
                   RESULTS         RESULTS       FORECAST    H1 FORECAST  
  Sales            290.14          290.50         285.00        140.00    
                 (-0.1 pct)      (-1.8 pct)     (-1.8 pct)    (-4.1 pct)  
  Operating         28.88           31.97          29.50         11.00    
                 (-9.7 pct)      (-23.3 pct)    (+2.2 pct)   (-21.0 pct)  
  Recurring         36.78           39.58          36.50         14.00    
                 (-7.1 pct)      (-22.8 pct)    (-0.7 pct)   (-20.8 pct)  
  Net 
  Net               22.47           24.53          24.00          9.00    
                 (-8.4 pct)      (-25.0 pct)    (+6.8 pct)   (-20.2 pct)  
  EPS            277.75 yen      302.57 yen     300.37 yen    112.63 yen  
  EPS Diluted    277.59 yen      302.42 yen                               
  Ann Div        100.00 yen      110.00 yen     110.00 yen                
  -Q2 Div         50.00 yen       50.00 yen      50.00 yen                
  -Q4 Div         50.00 yen       60.00 yen      60.00 yen                
   
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Taisho Pharmaceutical Holdings Co

See all news